HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.

Abstract
Specific targeting of ovarian carcinoma cells using pegylated polyethylenimine (PEG-PEI) conjugated to the antigen binding fragment (Fab') of the OV-TL16 antibody, which is directed to the OA3 surface antigen, was the objective of this study. OA3 is expressed by a majority of human ovarian carcinoma cell lines. To demonstrate the ability of the PEG-PEI-Fab' to efficiently complex DNA, an ethidium bromide exclusion assay was performed. Comparison with PEG-PEI or PEI 25 kDa showed only minor differences in the ability to condense DNA. Since conjugation of Fab' to PEG-PEI might influence complex stability, this issue was addressed by incubating the complexes with increasing amounts of heparin. This assay revealed stability similar to that of unmodified PEG-PEI/DNA or PEI 25 kDa/DNA complexes. Complexes displayed a size of approximately 150 nm with a zeta potential close to neutral. The latter property is of particular interest for potential in vivo use, since a neutral surface charge reduces nonspecific interactions. Binding studies using flow cytometry and fluorescently labeled DNA revealed a more than 6-fold higher degree of binding of PEG-PEI-Fab'/DNA complexes to epitope-expressing cell lines compared to unmodified PEG-PEI/DNA complexes. In OA3-expressing OVCAR-3 cells, luciferase reporter gene expression was elevated up to 80-fold compared to PEG-PEI and was even higher than that of PEI 25 kDa. The advantage of this system is its specificity, which was demonstrated by competition experiments with free Fab' in the cell culture media during transfection experiments and by using OA3-negative cells. In the latter case, only a low level of reporter gene expression could be achieved with PEG-PEI-Fab'.
AuthorsThomas Merdan, Jon Callahan, Holger Petersen, Klaus Kunath, Udo Bakowsky, Pavla Kopecková, Thomas Kissel, Jindrich Kopecek
JournalBioconjugate chemistry (Bioconjug Chem) 2003 Sep-Oct Vol. 14 Issue 5 Pg. 989-96 ISSN: 1043-1802 [Print] United States
PMID13129403 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Immunoglobulin Fab Fragments
  • Polyethylene Glycols
  • Polyethyleneimine
Topics
  • Animals
  • Cell Line, Tumor
  • Drug Delivery Systems (methods)
  • Female
  • Genetic Therapy (methods)
  • Humans
  • Immunoglobulin Fab Fragments (administration & dosage, chemistry, metabolism)
  • Male
  • Mice
  • NIH 3T3 Cells
  • Ovarian Neoplasms (drug therapy, genetics, metabolism)
  • Polyethylene Glycols (administration & dosage, chemistry, pharmacokinetics)
  • Polyethyleneimine (administration & dosage, chemistry, pharmacokinetics)
  • Salmon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: